Pharmalicensing brings you advice, commentary and analysis from industry experts.
Marcus Brady is Director of Corporate Development at Neurochem Inc. Lawrence Goldman is Web Marketing Manager at Decisioneering, Inc.
Marcus Brady, Director, Corporate Development at Neurochem Inc. Mr. Brady oversees Neurochem's corporate alliance initiatives with synergistic, fully integrated drug firms. Drawing upon an extensive background in technology licensing, venture capital, contract negotiation, intellectual property protection, research and development, and corporation alliance formation, he manages and expedites the commercialization of Neurochem technologies. Prior to joining Neurochem in August 1994, he led the pharmaceutical and medical business development and marketing activities of the National Research Council, Canada's largest research and development organization. In that role, he established corporate relationships, collaborative research ventures and licensing agreements with large and small biotechnology and pharmaceutical companies Mr. Brady holds an M.Sc. in Medical Physiology from the Health Sciences Centre of the University of Ottawa, Ontario, Canada, and a B.Sc. in Biochemistry from McGill University, Montreal, Quebec, Canada. He is an executive member of the Canadian Health Care Licensing Association. Lawrence Goldman, Web Marketing Manager, Decisioneering, Inc. Mr. Goldman currently directs Decisioneering's Web site development and Internet marketing strategies. During his tenure at the company, he has held positions as program manager, software trainer, and advanced technical support technician. Prior to 1997, he served as a technician in the mining software industry and as an exploration mining geologist. Mr. Goldman holds a M.S. in Geology from the University of Cincinnati, Cincinnati, Ohio, and B.A from Cornell University, Ithaca, New York.